SCHEMBL31359087

SCHEMBL31359087

C[C@H](NC(=O)Cn1c(=O)[nH]c2ccc(F)c(F)c2c1=O)c1ccc(C#N)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR139 Q6DWJ6 4/20 0.36
▸ B3GNT2 Q9NY97 4/20 0.35
▸ AURKA O14965 1/20 0.34
▸ GRK6 P43250 1/20 0.34
▸ PARP1 P09874 1/20 0.34
▸ JAK2 O60674 2/20 0.34
▸ JAK3 P52333 2/20 0.34
▸ JAK1 P23458 1/20 0.34
▸ TYK2 P29597 1/20 0.34
▸ TRPV1 Q8NER1 1/20 0.34
▸ CNR1 P21554 1/20 0.32
▸ CNR2 P34972 1/20 0.32
▸ ITGB1 P05556 1/20 0.32
▸ ITGAV P06756 1/20 0.32
▸ ITGA5 P08648 1/20 0.32
▸ ITGA4 P13612 1/20 0.32
▸ S1PR1 P21453 2/20 0.32
▸ S1PR3 Q99500 2/20 0.32
▸ USP1 O94782 1/20 0.32
▸ KDM4E B2RXH2 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31359109 1.00 GPR139 (0.36) GPR139B3GNT2AURKAGRK6PARP1
SCHEMBL31358975 0.92 GPR139 (0.38) GPR139B3GNT2AURKAGRK6JAK2
SCHEMBL31359078 0.92 GPR139 (0.38) GPR139B3GNT2AURKAGRK6JAK2
SCHEMBL31359006 0.90 GPR139 (0.35) GPR139B3GNT2PARP1JAK2JAK3
SCHEMBL31358997 0.90 GPR139 (0.35) GPR139B3GNT2PARP1JAK2JAK3
SCHEMBL31359019 0.87 PDPK1 (0.36) GPR139JAK2JAK3TRPV1CNR1
SCHEMBL31161003 0.87 PDPK1 (0.36) GPR139JAK2JAK3TRPV1CNR1
SCHEMBL31359032 0.86 GPR139 (0.34) GPR139TRPV1ITGB1ITGAVKDM4E
SCHEMBL31359088 0.86 GPR139 (0.34) GPR139TRPV1ITGB1ITGAVKDM4E
SCHEMBL31359083 0.86 ITGB1 (0.37) GPR139JAK2JAK3TRPV1ITGB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559464-B2 Quinazolinone dione compounds and uses thereof EDGEWISE THERAPEUTICS, INC. (US) 2026-02-24 — — US disclosed
US-20250026726-A1 QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF EDGEWISE THERAPEUTICS, INC. 2025-01-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250026726-A1 QUINAZOLINONE DIONE COMPOUNDS AND USES THEREOF TNNI3, TNNT2, MYLK2 GPR139 4045/4885B3GNT2 3193/4885AURKA 2094/4885
US-12559464-B2 Quinazolinone dione compounds and uses thereof TNNI3, TNNT2, TNNC1 GPR139 3566/4885B3GNT2 2417/4885AURKA 3907/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback